Daewon Pharmaceutical Overview
- Year Founded
-
1958
- Status
-
Public
- Employees
-
1,362
- Stock Symbol
-
003220
- Investments
-
6
- Share Price
-
$5.85
- (As of Thursday Closing)
Daewon Pharmaceutical General Information
Description
Daewon Pharmaceutical Co Ltd is active in the healthcare sector in Korea. Its main business involves antipyretics, respiratory drugs, cardiovascular drugs, and neuromuscular drugs. It also produces a range of health foods such as multivitamins. The company operates on a global basis.
Contact Information
Website
www.daewonpharm.comCorporate Office
- 386, Cheonho-daero
- Sungdong-gu
- Seoul, 04808
- South Korea
Corporate Office
- 386, Cheonho-daero
- Sungdong-gu
- Seoul, 04808
- South Korea
Daewon Pharmaceutical Stock Performance
As of 12-Nov-2026, Daewon Pharmaceutical’s stock price is $5.85. Its current market cap is $125M with 21.4M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.85 | $5.88 | $4.65 - $9.23 | $125M | 21.4M | 111K | $0.08 |
Daewon Pharmaceutical Financials Summary
As of 30-Jun-2026, Daewon Pharmaceutical has a trailing 12-month revenue of $424M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 198,046 | 284,467 | 294,314 | 322,734 |
| Revenue | 423,521 | 425,423 | 438,395 | 403,038 |
| EBITDA | 27,068 | 22,791 | 32,267 | 35,738 |
| Net Income | 1,814 | (969) | 10,414 | 18,293 |
| Total Assets | 371,565 | 426,144 | 396,063 | 394,201 |
| Total Debt | 122,586 | 140,301 | 127,118 | 113,333 |
Daewon Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Daewon Pharmaceutical Patents
Daewon Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025206834-A1 | Heterobicyclic derivative and pharmaceutical composition comprising same | Pending | 29-Mar-2024 | ||
| WO-2025188088-A1 | Tricyclic derivative and pharmaceutical composition comprising same | Pending | 07-Mar-2024 | ||
| WO-2025188088-A8 | Tricyclic derivative and pharmaceutical composition comprising same | Pending | 07-Mar-2024 | ||
| WO-2024225792-A1 | Analgesic pharmaceutical composition comprising pelubiprofen and tramadol | Inactive | 27-Apr-2023 | ||
| WO-2024136035-A1 | Semaglutide-containing microneedles and manufacturing method therefor | Inactive | 23-Dec-2022 | A61M37/0015 |
Daewon Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Daewon Pharmaceutical Investments & Acquisitions (6)
Daewon Pharmaceutical’s most recent deal was a Later Stage VC with Prazer Therapeutics for . The deal was made on 09-Mar-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Prazer Therapeutics | 09-Mar-2025 | Later Stage VC | Drug Discovery | ||
| SD Biotechnologies | 01-Dec-2023 | Merger/Acquisition | Personal Products | ||
| L-base | 01-Jan-2023 | Later Stage VC | Drug Discovery | ||
| Glaceum | 14-Apr-2022 | Later Stage VC | Drug Discovery | ||
| Keukdong H-Pharm | 12-May-2021 | Merger/Acquisition | Pharmaceuticals |
Daewon Pharmaceutical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Daewon Pharmaceutical Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SD Biotechnologies | Seoul, South Korea | 2008 |
Daewon Pharmaceutical FAQs
-
When was Daewon Pharmaceutical founded?
Daewon Pharmaceutical was founded in 1958.
-
Where is Daewon Pharmaceutical headquartered?
Daewon Pharmaceutical is headquartered in Seoul, South Korea.
-
What is the size of Daewon Pharmaceutical?
Daewon Pharmaceutical has 1,362 total employees.
-
What industry is Daewon Pharmaceutical in?
Daewon Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Daewon Pharmaceutical a private or public company?
Daewon Pharmaceutical is a Public company.
-
What is Daewon Pharmaceutical’s stock symbol?
The ticker symbol for Daewon Pharmaceutical is 003220.
-
What is the current stock price of Daewon Pharmaceutical?
As of 12-Nov-2026 the stock price of Daewon Pharmaceutical is $5.85.
-
What is the current market cap of Daewon Pharmaceutical?
The current market capitalization of Daewon Pharmaceutical is $125M.
-
What is Daewon Pharmaceutical’s current revenue?
The trailing twelve month revenue for Daewon Pharmaceutical is $424M.
-
What is Daewon Pharmaceutical’s annual earnings per share (EPS)?
Daewon Pharmaceutical’s EPS for 12 months was $0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
